|
UNITED
STATES |
OMB APPROVAL |
|
OMB Number: 3235-0582 |
|
|
Expires: April 30, 2009 |
|
|
Estimated average burden hours per response......14.4 |
FORM N-PX
ANNUAL
REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number 811- 04889
H&Q Healthcare Investors
(Exact name of registrant as specified in charter)
30 Rowes Wharf, Boston, MA |
|
02110 |
(Address of principal executive offices) |
|
(Zip code) |
Carolyn Haley
H&Q Healthcare Investors
30 Rowes Wharf, Boston MA 02110
(Name and address of agent for service)
Registrants telephone number, including area code: 617 772-8500
Date of fiscal year end: September 30
Date of reporting period: 7/1/06-6/30/07
Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss.239.24 and 274.5 of this chapter), to file reports with the Commission, not later than August 31 of each year, containing the registrants proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (OMB) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.
Item 1. Proxy Voting Record.
HQH N-PX for the period July 1, 2006 to June 30, 2007 |
|
|||||
|
|
|
|
|||
CUSIP |
|
Symbol |
Company Name |
|
|
|
|
|
|
|
|
|
|
004225108 |
|
ACAD |
Acadia Pharmaceuticals, Inc. |
|
|
|
Meeting Date: |
6/15/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/16/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Gordon Binder |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Leslie L. Iversen |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the selection by the audit committee of our board of directors of Pricewaterhousecoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
Agensys, Inc. |
|
|
Action by Written Consent: |
6/29/2007 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Approval of amended and restated articles of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Disclosure of interested parties in stock financing |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Waiver of notice and right of first refusal |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
General authorization |
|
For |
|
Yes |
|
For |
|
Management |
|
009728106 |
|
AKRX |
Akorn, Inc. |
|
|
|
Meeting Date: |
5/24/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/12/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director John N. Kapoor, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Arthur S. Przybyl |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Jerry N. Ellis |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Ronald M. Johnson |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Jerry I. Treppel |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Subhash Kapre, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Randall J. Wall |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Proposal to ratify the selection of BDO Seidman, LLP to serve as Akorns independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
1
016255101 |
|
ALGN |
Align Technology, Inc. |
|
|
|
Meeting Date: |
5/23/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/30/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director H. Kent Bowen |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director David E. Collins |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Joseph Lacob |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director C. Raymond Larking, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director George J. Morrow |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Thomas M. Prescott |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Greg J. Santora |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Warren S. Thaler |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Proposal to ratify the appointment of Pricewatershousecoopers LLP as Algin Technology, Inc.s independent registered public accountants for the fiscal year dending December 31, 2007. |
|
For |
|
Yes |
|
For |
|
Management |
|
018490102 |
|
AGN |
Allergan, Inc. |
|
|
|
Meeting Date: |
5/1/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/14/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Michael R. Gallagher |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Gavin S. Herbert |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Stephen J. Ryan, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the appointment of Ernst & Young LLP as the companys independent registered public accounting firm for the fiscal year 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
01988P108 |
|
MDRX |
Allscripts Healthcare Solutions, Inc. |
|
|
|
Meeting Date: |
6/19/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/23/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Robert A. Compton |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Michael J. Kluger |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director John P. McConnell |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approval of the amendment to the Allscripts Healthcare Solutions, Inc. amended and restated 1993 stock incentive plan |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Ratification of the appointment of Grant Thornton LLP as independent accountants for 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
2
02744M108 |
|
AMMD |
American Medical Systems Holdings, Inc. |
|
||
Meeting Date: |
5/30/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/2/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Martin J. Emerson |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Albert Jay Graf |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Robert Mclellan, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Proposal to ratify the selection of Ernst & Young LLP as independent auditors for 2007. |
|
For |
|
Yes |
|
For |
|
Management |
|
031162100 |
|
AMGN |
Amgen, Inc. |
|
|
|
Meeting Date: |
5/9/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/12/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Frank J. Biondi, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Jerry D. Choate |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Frank C. Herringer |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Gilbert S. Omenn |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Ratify the selection of Ernst & Young LLP as the companys independent registered public accountants for the year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To approve the amendments to the companys restated certificate of incorporation eliminating the classification of the board of directors |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
To approve the amendments to the companys amended and restated bylaws eliminating the classification of the board of directors |
|
For |
|
Yes |
|
For |
|
Management |
|
5 |
|
Shareholder proposal #1 on animal welfare policy |
|
Against |
|
Yes |
|
Against |
|
Shareholder |
|
6 |
|
Shareholder proposal #2 on sustainability report |
|
Against |
|
Yes |
|
Against |
|
Shareholder |
|
032346108 |
|
AMLN |
Amylin Pharmaceuticals, Inc. |
|
|
|
Meeting Date: |
5/23/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/30/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Steven R. Altman |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Teresa Beck |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Daniel M. Bradbury |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Joseph C. Cook, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Karin Eastham |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director James R. Gavin III |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Ginger L. Graham |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Howard E. Greene, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
3
1 |
|
Elect Director Jay S. Skyler |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Joseph P. Sullivan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director James N. Wilson |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve an increase of 250,000 shares in the aggregate number of shares of the companys common stock authorized for issuance under the companys amended and restated certificate of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To approve an increase of 1,000,000 shares in the aggregate number of shares of the companys common stock authorized for issuance under the companys 2001 employee stock purchase plan |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
To ratify the selection of Ernst & Young LLP as independent auditors of the company for its fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
04538T109 |
|
ASPV |
Aspreva Pharmaceuticals Corporation |
|
||
Meeting Date: |
5/31/2007 |
Meeting Type: |
Annual and Special |
|||
Record Date: |
4/19/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Richard M. Glickman |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Noel F. Hall |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Kirk K. Calhoun |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Ronald M. Hunter |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director William L. Hunter |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Julia G. Levy |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director R. Hector Mackay-Dunn |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director George M. Milne |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Arnold L. Oronsky |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To appoint Ernst & Young LLP as our auditor and independent registered public accounting firm for the ensuing year |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To amend the Aspreva 2002 incentive stock option plan to increase from 4,031,000 to 5,281,000 common shares in respect of which awards may be granted thereunder |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
To amend the Aspreva 2002 incentive stock option plan to (I) comply with recent policies of the Toronto stock exchange: (II) premit the award to tandem stock appreciation rights, restricted stock units and deferred stock units: and (III) certain other changes |
|
For |
|
Yes |
|
For |
|
Management |
|
5 |
|
To transact such other business as may properly come before the meeting, or any adjournments or postponements thereof |
|
For |
|
Yes |
|
For |
|
Management |
|
4
05346P106 |
|
AVRX |
Avalon Pharmacetucals, Inc. |
|
|
|
Meeting Date: |
6/7/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/20/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director K.C. Carter, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director D.S. Kabakoff, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Michael R. Kurman, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Bradley G. Lorimier |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Ivor Royston, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director William A. Scott, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director A.G. Walton, Ph.D., D.Sc. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director William H. Washecka |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve the amendment of the companys 2005 omnibus long-term incentive plan (the incentive plan) to increase the number of shares available for issuance under the incentive plan from 1,581,582 shares to 2,381,582 shares |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To ratify the appointment of Ernst & Young LLP as the companys independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
05365U101 |
|
AVTQY |
Aveta Inc. 144A |
|
|
|
Meeting Date: |
10/20/2006 |
Meeting Type: |
Annual |
|||
Record Date: |
9/19/2006 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Christina Foglio |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
elect Director George Zoffinger |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve the Aveta Inc. amended and restated 2005 stock incentive plan |
|
For |
|
Yes |
|
For |
|
Management |
|
068306109 |
|
BRL |
Barr Pharmaceuticals, Inc. |
|
|
|
Meeting Date: |
11/9/2006 |
Meeting Type: |
Annual |
|||
Record Date: |
9/15/2006 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Bruce L. Downey |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Paul M. Bisaro |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director George P. Stephan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Harold N. Chefitz |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Richard R. Frankovic |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Peter R. Seaver |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director James S. Gilmore, III |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Ratification of the selection of Deloitte & Touche LLP as the independent auditor of the company for the six month period ending Decmeber 31, 2006 |
|
For |
|
Yes |
|
For |
|
Management |
|
5
068306109 |
|
BRL |
Barr Pharmaceuticals, Inc. |
|
|
|
Meeting Date: |
5/17/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/30/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Bruce L. Downey |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Paul M. Bisaro |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director George P. Stephan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Harold N. Chefitz |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Richard R. Frankovic |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Peter R. Seaver |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director James S. Gilmore, III |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the Audit Committees selection of the companys independent registered public accounting firm for the year ending December 31, 2007. |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To approve the Barr Pharmaceuticals, Inc. 2007 stock and incentive award plan |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
To approve the Barr Pharmaceuticals, Inc. 2007 executive officer incentive plan |
|
For |
|
Yes |
|
For |
|
Management |
|
06850R108 |
|
BTRX |
Barrier Therapeutics, Inc. |
|
|
|
Meeting Date: |
6/6/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/16/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director S. Akkaraju, MD, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Robert E. Campbell |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Geert Cauwenbergh, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the company for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
09062X103 |
|
BIIB |
Biogen Idec, Inc. |
|
|
|
Meeting Date: |
5/31/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/13/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director James C. Mullen |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Bruce R. Ross |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Marijn E. Dekkers |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the selection of Pricewaterhousecoopers LLP as the companys independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
6
|
|
|
CardioNet, Inc. |
|
|
Action by Written Consent: |
8/21/2006 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Approve financing; articles of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Waiver of rights of first offer |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Additional filings |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
Ratification; general authorizing resolution |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
CardioNet, Inc. |
|
|
Action by Written Consent: |
1/11/2007 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Increase in share reserve under equity incentive plan |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approval of amendment and restatement of articles of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
General authorizing resolution; ratification of past acts |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
CardioNet, Inc. |
|
|
Action by Written Consent: |
3/30/2007 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Approval of financing |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approval of amendment and restatement of articles of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Approval of additional filings |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
General authorizing resolution |
|
For |
|
Yes |
|
For |
|
Management |
|
151020104 |
|
CELG |
Celgene Corporation |
|
|
|
Meeting Date: |
6/12/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/26/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Sol J. Barer, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Robert J. Hugin |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Michael D. Casey |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Rodman L. Drake |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director A. Hull Hayes, Jr., MD |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Gilla Kaplan, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director James J. Loughlin |
|
For |
|
Yes |
|
For |
|
Management |
|
7
1 |
|
Elect Director Richard C.E. Morgan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Walter L. Robb, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
156708109 |
|
CEPH |
Cephalon, Inc. |
|
|
|
Meeting Date: |
5/17/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/22/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Frank Bladino, Jr., Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director William P. Egan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Martyn D. Greenacre |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Vaughn M. Kailian |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Kevin E. Moley |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Charles A. Sanders, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Gail R. Wilensky, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Dennis L. Winger |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approval of amendment to the certificate of incorporation increasing the number of shares of common stock authorized for issuance |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Approval of amendment to the 2004 equity compensation plan increasing the number of shares of common stock authorized for issuance |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
Ratification of appointment of Pricewaterhousecoopers LLP as independent registered public accountants for the year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
N/A |
|
N/A |
Ceres, Inc. |
|
|
|
Meeting Date: |
5/31/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/26/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Walter De Logi |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Pascal Brandys |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Frank Bulens |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Raymond Debbane |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Robert Goldberg |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Richard Hamilton |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Thomas Kiley |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Edmund Olivier |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Floris Vansina |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Ratification of the appointment of KPMG LLP as independent public accountants |
|
For |
|
Yes |
|
For |
|
Management |
|
8
|
|
|
Ceres, Inc. |
|
|
Action by Written Consent: |
5/8/2007 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Election of Directors |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
Concentric Medical, Inc. |
|
|
Action by Written Consent: |
8/30/2006 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Appointment of Secretary and Assistant Secretary |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Omnibus resolutions |
|
For |
|
Yes |
|
For |
|
Management |
|
208264101 |
|
CONR |
Conor Medsystems, Inc. |
|
|
|
Meeting Date: |
1/31/2007 |
Meeting Type: |
Special |
|||
Record Date: |
12/15/2006 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
To adopt the agreement and plan of merger, dated as of November 16, 2006, by and among Conor Medsystems, Inc., Johnson & Johnson and Cypress Acquisition Sub, Inc., a wholly owned subsidiary of Johnson & Johnson, pursuant to which Merger Sub will be merged with and into Conor Medsystems all as more fully described in the proxy statement |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve the postponement or adjournment of the special meeting, if necessary, to solicit additional proxies in the event that there are insufficient votes at the time of the special meeting to adopt the merger agreement. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
Corus Pharma, Inc. |
|
|
Action by Written Consent: |
8/30/2006 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Approval of benefits to employee |
|
For |
|
Yes |
|
For |
|
Management |
|
222083107 |
|
CGRB |
Cougar Biotechnology, Inc. |
|
|
|
Meeting Date: |
6/11/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/23/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Arie S. Belldegrun, MD, FACS |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Alan H. Auerbach |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Lindsay A. Rosenwald, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
9
1 |
|
Elect Director Harold J. Meyers |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Michael S. Richman |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Russell H. Ellison, MD, MSC |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Proposal to ratify the appointment of JH Cohn LLP as the companys independent registered public accounting firm for 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Proposal to ratify an amendment to the companys 2003 stock option plan |
|
For |
|
Yes |
|
For |
|
Management |
|
229678107 |
|
CBST |
Cubist Pharmaceuticals, Inc. |
|
|
|
Meeting Date: |
6/7/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/12/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Michael W. Bonney |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Walter R. Maupay, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Sylvie Gregoire |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
A proposal to amend our restated certificate of incorporation to increase the number of authorized shares of common stock from 100,000 shares to 150,000,000 shares |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
A proposal to amend our amended and restated 1997 employee stock purchase plan to extend the plan for an additional ten years and increase the number of shares issuable under the plan by 250,000 |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
A proposal to amend our amended and restated 2002 directors equity incentive plan to allow for the issuance of stock awards and to increase the number of shares issuable under the plan by 300,000 |
|
For |
|
Yes |
|
For |
|
Management |
|
5 |
|
A proposal to ratify the selection of Pricewaterhousecoopers LLP as our independent auditor for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
259858108 |
|
DOVP |
DOV Pharmaceutical, Inc. |
|
|
|
Meeting Date: |
5/11/2007 |
Meeting Type: |
Special |
|||
Record Date: |
4/2/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Approve an amendment to DOV Pharmaceutical, Inc.s fourth amended and restated certificate of incorporation to increase the number of authorized shares of common stock by 200,000,000, from 60,000,000 to 260,000,000, together with a corresponding increase in the number of authorized shares of capital stock from 66,905,000 to 266,905,000 |
|
For |
|
Yes |
|
For |
|
Management |
|
10
23325G104 |
|
DJO |
DJO, Inc. |
|
|
|
Meeting Date: |
6/4/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/18/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Jack R. Blair |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Mitchell J. Blutt, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director W. Thomas Mitchell |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve an amendment to the companys amended and restated certificate of incorporation to increase the authorized number of shares of common stock from 39,000,000 to 79,000,000 shares |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To ratify the appointment of Ernst & Young LLP as the companys independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
29076V109 |
|
EMAG |
Emageon, Inc. |
|
|
|
Meeting Date: |
5/24/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/25/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Mylle H. Mangum |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Hugh H. Williamson, III |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Proposal to ratify the appointment of Ernst & Young LLP as the companys independent registered public accounting firm for the current fiscal year |
|
For |
|
Yes |
|
For |
|
Management |
|
290849108 |
|
HLTH |
Emdeon Corporation |
|
|
|
Meeting Date: |
9/12/2006 |
Meeting Type: |
Annual |
|||
Record Date: |
7/25/2006 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Paul A. Brooke |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director James V. Manning |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Martin J. Wygod |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve an amendment to Emdeons 2000 long-term incentive plan to increase the number of shares reserved for issuance. |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm to serve as Emdeons independent auditor for the fiscal year ending December 31, 2006. |
|
For |
|
Yes |
|
For |
|
Management |
|
11
30161Q104 |
|
EXEL |
Exelixis, Inc. |
|
|
|
Meeting Date: |
5/1/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/5/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Alan M. Garber |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Vincent T. Marchesi |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Carl B. Feldbaum |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the selection of Ernst & Young LLP as Exelixis independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
345838106 |
|
FRX |
Forest Laboratories, Inc. |
|
|
|
Meeting Date: |
8/7/2006 |
Meeting Type: |
Annual |
|||
Record Date: |
6/20/2006 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Howard Solomon |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Nesli Basgoz, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director William J. Candee, III |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director George S. Cohan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Dan L. Goldwasser |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Kenneth E. Goodman |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Lester B. Salans, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Ratification of BDO Seidman, LLP as independent registered public accounting firm |
|
For |
|
Yes |
|
For |
|
Management |
|
368710406 |
|
DNA |
Genentech, Inc. |
|
|
|
Meeting Date: |
4/20/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
2/20/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Herbert W. Boyer |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director William M. Burns |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Erich Hunziker |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Jonathan K.C. Knowles |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Arthur D. Levinson |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Debra L. Reed |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Charles A. Sanders |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the selection of Ernst & Young LLP as independent registrered public accounting firm of Genentech for the year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
12
372917104 |
|
GENZ |
Genzyme Corporation |
|
|
|
Meeting Date: |
5/24/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/30/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Douglas A. Berthiaume |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Gail K. Boureaux |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
A proposal to amend the 2004 equity incentive plan to increase the number of shares of common stock covered by the plan by 3,500,000 shares and to merge our 1997 equity incentive plan into the 2004 plan |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
A proposal to approve the 2007 director equity plan |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
A proposal to amend the 1999 employee stock purchase plan to increase the number of shares of common stock covered by the plan by 1,500,000 shares |
|
For |
|
Yes |
|
For |
|
Management |
|
5 |
|
A proposal to amend our bylaws to provide for majority voting for the election of directors in uncontested elections |
|
For |
|
Yes |
|
For |
|
Management |
|
6 |
|
A proposal to ratify the selection of independent auditors for 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
7 |
|
A shareholder proposal that executive severance agreements be approved by shareholders |
|
Against |
|
Yes |
|
Against |
|
Management |
|
375558103 |
|
GILD |
Gilead Sciences, Inc. |
|
|
|
Meeting Date: |
5/9/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/22/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Paul Berg |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director John F. Cogan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Etienne F. Davignon |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director James M. Denny |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Carla A. Hills |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director John W. Madigan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director John C. Martin |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Gordon E. Moore |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Nicholas G. Moore |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Gayle E. Wilson |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the selection of Ernst & Young LLP by the Audit Committee of the board of directors as the independent registered public accounting firm of Gilead for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To approve the proposed amendment to Gileads 2004 equity incentive plan |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
To approve the proposed amendment to Gileads employee stock purchase plan |
|
For |
|
Yes |
|
For |
|
Management |
|
13
422211102 |
|
HLEX |
Healthextras, Inc. |
|
|
|
Meeting Date: |
6/5/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/13/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Thomas L. Blair |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director William E. Brock |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Edward S. Civera |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approval of the Healthextras, Inc. management non-equity incentive compensation plan |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
The ratification of the appointment of Pricewatershousecoopers LLP as independent registered public accountants of Healthextras, Inc. for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
45166R204 |
|
IDIX |
Idenix Pharmaceuticals, Inc. |
|
|
|
Meeting Date: |
5/31/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/5/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director J-P Sommadossi, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Charles W. Cramb |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Thomas Ebeling |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director W.T. Hockmeyer, Ph.D. |